Anti-LEF1 抗体 [EPR2029Y]
Anti-LEF1 antibody [EPR2029Y]
- BOND RX™ Validated
- 20ul selling size
- RabMAb
- Recombinant
- KO Validated
- 詳細を見る
5
(3 Reviews)
|
(69 Publications)
Anti-LEF1 antibody [EPR2029Y] (ab137872) is a rabbit monoclonal antibody detecting LEF1 in Western Blot, Flow Cytometry (Intra), Flow Cytometry, IP, IHC-P, ICC/IF. Suitable for Human, Mouse, Rat.
- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 60 publications
別名を表示する
Lymphoid enhancer-binding factor 1, LEF-1, T cell-specific transcription factor 1-alpha, TCF1-alpha, LEF1
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LEF1 antibody [EPR2029Y] (AB137872)
ab137872 staining LEF1 in paraffin embedded human melanoma tissue by Immunohistochemistry. Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins. Samples were incubated with primary antibody at 1/2000 dilution for 30 mins at room temperature. A ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101) was used as the secondary antibody. Hematoxylin was used as a counterstain. The immunostaining was performed on a Leica Biosystems BOND® RX instrument.
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-LEF1 antibody [EPR2029Y] (AB137872)
Flow cytometry overlay histogram showing left Jurkat positive cells and right negative HeLa stained with ab137872 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilised with 0.1% PBS-Triton X-100 for 15 min. The cells were then incubated in 1x PBS containing 10% normal goat serum to block non-specific protein-protein interaction followed by the antibody (ab137872) (1x 106 in 100μl at 0.2μg/ml (1/11500 dilution)) for 30min at 22°C.The secondary antibody Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed was incubated at 1/4000 for 30min at 22°CIsotype control antibody (black line) was Recombinant Rabbit IgG monoclonal [EPR25A] - Isotype Control used at the same concentration and conditions as the primary antibody. Unlabelled sample (blue line) was also used as a control.Acquisition of >5000 events were collected using a 50 mW Blue laser (488nm) and 525/40 bandpass filter.This antibody gave a positive signal in Jurkat Fixed with 4% formaldehyde (10 min) / permeabilised with 0.1% PBS-Triton X-100 for 15 min under the same conditions.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LEF1 antibody [EPR2029Y] (AB137872)
ab137872 staining LEF1 in paraffin embedded human thymona tissue by Immunohistochemistry. Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins. Samples were incubated with primary antibody at 1/2000 dilution for 30 mins at room temperature. A ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101) was used as the secondary antibody. Hematoxylin was used as a counterstain. The immunostaining was performed on a Leica Biosystems BOND® RX instrument.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LEF1 antibody [EPR2029Y] (AB137872)
ab137872 staining LEF1 in paraffin embedded human melanoma tissue by Immunohistochemistry. Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0 Epitope Retrieval Solution2) for 20 mins. Samples were incubated with primary antibody at 1/2000 dilution for 30 mins at room temperature. A ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101) was used as the secondary antibody. Hematoxylin was used as a counterstain. The immunostaining was performed on a Leica Biosystems BOND® RX instrument.
- WB
Unknown
Western blot - Anti-LEF1 antibody [EPR2029Y] (AB137872)
Blocking/Dilution buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-LEF1 antibody [EPR2029Y] (ab137872) at 1/1000 dilution
All lanes:
Human fetal thymus lysate at 10 µg
Secondary
All lanes:
HRP goat anti-rabbit (H+L) at 1/1000 dilution
Predicted band size: 44 kDa
false
- WB
Unknown
Western blot - Anti-LEF1 antibody [EPR2029Y] (AB137872)
Blocking/Dilution buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-LEF1 antibody [EPR2029Y] (ab137872) at 1/10000 dilution
All lanes:
Jurkat (Human T cell leukemia cell line from peripheral blood) cell lysate at 10 µg
Secondary
All lanes:
HRP goat anti-rabbit (H+L) at 1/1000 dilution
Predicted band size: 44 kDa
false
- WB
Unknown
Western blot - Anti-LEF1 antibody [EPR2029Y] (AB137872)
Blocking/Dilution buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-LEF1 antibody [EPR2029Y] (ab137872) at 1/2000 dilution
All lanes:
Rat thymus tissue lysate at 20 µg
Secondary
All lanes:
HRP goat anti-rabbit (H+L) at 1/1000 dilution
Predicted band size: 44 kDa
false
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-LEF1 antibody [EPR2029Y] (AB137872)
Intracellular flow cytometric analysis of Jurkat cell line (human T cell leukemia T lymphocyte) fixed with 4% paraformaldehyde and permeabilized with 90% methanol labeling LEF1 with ab137872 at 1/600 dilution (red). This is compared with a Rabbit monoclonal IgG (ab172730) - Isotype control (black) and a unlabeled control (cells without incubation with primary antibody and secondary antibody) (blue). Goat anti-rabbit IgG (Alexa Fluor®488) was used as the secondary antibody.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-LEF1 antibody [EPR2029Y] (AB137872)
Immunofluorescence staining of Jurkat (Human T cell leukemia cell line from peripheral blood) cells with purified ab137872 at a working dilution of 1 in 500 counter-stained with DAPI. Tubulin was stained with mouse anti-tubulin at a dilution of 1/1000 (ab7291) and Alexa Fluor® 594 goat anti-mouse at a dilution of 1/500 (ab150120) . The secondary antibody was ab150077 Alexa Fluor® 488 goat anti rabbit used at a dilution of 1 in 500. The cells were fixed in 4% PFA and permeabilized using 0.1% Triton X 100.
The negative controls are shown in the bottom middle and right hand panels - for the first negative control purified ab137872 was used at a dilution of 1/200 followed by an Alexa Fluor® 555 goat anti-mouse antibody at a dilution of 1/500 and for the second negative control mouse primary antibody (ab7291) and anti-rabbit secondary antibody (ab15007) were used.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LEF1 antibody [EPR2029Y] (AB137872)
Immunohistochemical staining of paraffin embedded human tonsil with purified ab137872 at a working dilution of 1/500. The secondary antibody used is ab97051 an HRP-conjugated goat anti-rabbit IgG (H+L) at a dilution of 1/500. The sample is counter-stained with hematoxylin. Antigen retrieval was perfomed using Tris-EDTA buffer pH 9.0. PBS was used instead of the primary antibody as the negative control and is shown in the inset.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LEF1 antibody [EPR2029Y] (AB137872)
Immunohistochemical staining of paraffin embedded rat spleen with purified ab137872 at a working dilution of 1/500. The secondary antibody used is ab97051, an HRP-conjugated goat anti-rabbit IgG (H+L), at a dilution of 1/500. The sample is counter-stained with hematoxylin. Antigen retrieval was perfomed using Tris-EDTA buffer, pH 9.0. PBS was used instead of the primary antibody as the negative control, and is shown in the inset.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LEF1 antibody [EPR2029Y] (AB137872)
Immunohistochemical staining of paraffin-embedded human thymus with purified ab137872 at a working dilution of 1/500. The secondary antibody used is ab97051 an HRP-conjugated goat anti-rabbit IgG (H+L) at a dilution of 1/500. The sample is counter-stained with hematoxylin. Antigen retrieval was perfomed using Tris-EDTA buffer pH 9.0. PBS was used instead of the primary antibody as the negative control and is shown in the inset.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LEF1 antibody [EPR2029Y] (AB137872)
Tissue Microarrays stained for Anti-LEF1 antibody [EPR2029Y] using ab137872 in immunohistochemical analysis. This table provides a detailed overview of positive (tick mark) and negaive (cross mark) staining per sample type tested. The sections were incubated with ab137872 for 30 mins at room temperature used at 1 : 2000 dilution (1.05 μg/ml) followed by a ready to use Rabbit specific IHC polymer detection kit HRP/DAB secondary antibody (ab209101). Counterstain was Hematoxylin. Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins. The immunostaining was performed on a Leica Biosystems BOND® RX instrument.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LEF1 antibody [EPR2029Y] (AB137872)
Immunohistochemical analysis of formalin fixed paraffin embedded human tonsil labelling LEF1 with ab137872 at a concentration of 0.5 µg/ml. The immunostaining was performed on a Ventana DISCOVERY ULTRA (Roche Tissue Diagnostics) instrument with an OptiView DAB IHC Detection Kit. Heat mediated antigen retrieval was conducted for 32 mins at 100°C with ULTRA cell conditioning solution (CC1, pH 8.5). ab137872 anti LEF1 antibody [EPR2029Y] was incubated at 37°C for 16 mins. Sections were counterstained with Hematoxylin II. Image inset shows absence of staining in secondary antibody only control.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LEF1 antibody [EPR2029Y] (AB137872)
ab137872 staining LEF1 in paraffin embedded mouse spleen tissue by Immunohistochemistry. Antigen retrieval was performed by heat mediation using ab93684 (Tris/EDTA buffer, ph 9). Samples were incubated with primary antibody at 1/2000 dilution. A ready to use Goat Anti-rabbit IgG H&L (HRP) was used as the secondary antibody. Hematoxylin was used as a counterstain. Nuclear staining on T cells in periarterial lymphatic sheath of mouse spleen is observed (PMID : 21685909).
- IP
Lab
Immunoprecipitation - Anti-LEF1 antibody [EPR2029Y] (AB137872)
Lane 1 (input) : Jurkat (human T cell leukemia T lymphocyte) whole cell lysate, 10 μg
Lane 2 (+) : Jurkat whole cell lysate
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab137872 in Jurkat whole cell lysate
ab137872 immunoprecipitating LEF1 in Jurkat whole cell lysate. For western blotting, primary antibody used was ab137872 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10,000 dilution.
Blocking and diluting buffer : 5% NFDM/TBST
Exposure time : 3 minutes
All lanes:
Immunoprecipitation - Anti-LEF1 antibody [EPR2029Y] (ab137872)
Predicted band size: 44 kDa
false
Exposure time: 3min
- IP
Lab
Immunoprecipitation - Anti-LEF1 antibody [EPR2029Y] (AB137872)
Lane 1 (input) : Rat thymus lysate, 10μg
Lane 2 (+) : Rat thymus lysate
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab137872 in rat thymus lysate
ab137872 immunoprecipitating LEF1 in rat thymus lysate. For western blotting, primary antibody used was ab137872 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10,000 dilution.
Blocking and diluting buffer : 5% NFDM/TBST
Exposure time : 3 minutes
All lanes:
Immunoprecipitation - Anti-LEF1 antibody [EPR2029Y] (ab137872)
Predicted band size: 44 kDa
false
Exposure time: 3min
- WB
Lab
Western blot - Anti-LEF1 antibody [EPR2029Y] (AB137872)
Different batches of ab137872 were tested on Jurkat (Human T cell leukemia T lymphocyte) lysate at 1.1 µg/ml. 15 µg of lysate was loaded in each lane. Bands observed at 25-57 kDa.
All lanes:
Western blot - Anti-LEF1 antibody [EPR2029Y] (ab137872)
Predicted band size: 44 kDa
false
- WB
Lab
Western blot - Anti-LEF1 antibody [EPR2029Y] (AB137872)
False colour image of Western blot : Anti-LEF1 antibody [EPR2029Y] staining at 1/1000 dilution, shown in black; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab137872 was shown to bind specifically to LEF1. A band was observed at 40/53 kDa in wild-type Jurkat cell lysates with no signal observed at this size in Lef1 knockout cell line ab274898 (knockout cell lysate ab274956). To generate this image, wild-type and Lef1 knockout Jurkat cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3% milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times before development with Optiblot (ECL reagent ab133456) and imaged with 4 minutes exposure time. Secondary antibodies used were HRP conjugated Goat anti-Rabbit (H+L) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.
All lanes:
Western blot - Anti-LEF1 antibody [EPR2029Y] (ab137872) at 1/1000 dilution
Lane 1:
Wild-type Jurkat cell lysate at 40 µg
Lane 2:
Lef1 knockout Jurkat cell lysate at 40 µg
Lane 2:
Western blot - Human LEF1 knockout Jurkat cell line (<a href='/products/cell-lines/human-lef1-knockout-jurkat-cell-line-ab274898'>ab274898</a>)
Lane 3:
Jurkat cell lysate at 20 µg
Predicted band size: 44 kDa
Observed band size: 40 kDa
false
- WB
Lab
Western blot - Anti-LEF1 antibody [EPR2029Y] (AB137872)
Blocking and diluting buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-LEF1 antibody [EPR2029Y] (ab137872) at 1/1000 dilution
All lanes:
His-tagged mouse LEF-1 recombinant protein (aa1-397) at 0.01 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 44 kDa
Observed band size: 44 kDa
false
Exposure time: 1s
関連する標識済み抗体及び組成の異なる製品 (4)
-
HRP Anti-LEF1 antibody [EPR2029Y]
-
Anti-LEF1 antibody [EPR2029Y] - BSA and Azide free
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-LEF1 antibody [EPR2029Y]
-
660 APC
APC Anti-LEF1 antibody [EPR2029Y]
Reactivity data
下記製品にもご興味をお持ちいただけるかもしれません:
こちらの製品も推奨する理由
この製品は、同様の実験や関連する研究で広く使用されていることから推奨させていただいております。
お客様の実験に適するかご確認いただくため、必ず製品データシートをご確認いただくことをお勧めいたします。ご不明点等ございましたら、テクニカルサポートチームまでお問い合わせください。
製品の詳細
Anti-LEF1 antibody [EPR2029Y] (ab137872) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt (Intra), ICC/IF, IHC-P, IP and WB.
Abcam's high quality manufacturing and validation processes ensure Anti-LEF1 antibody [EPR2029Y] (ab137872) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.
The specificity of Anti-LEF1 antibody [EPR2029Y] (ab137872) has been confirmed by Western Blot testing in LEF1 knockout Jurkat cells (ab274898).
Anti-LEF1 antibody [EPR2029Y] (ab137872) specifically detects LEF1 (UniProt ID: Q9UJU2; Molecular weight: 45kDa) and is sold in a convenient trial size to enable initial testing (20 µL) and larger sizes for subsequent scaling up experiments (100 µL and 1 mL).
Conjugation-ready, carrier free format available for antibody clone EPR2029Y - ab215999.
Antibody clone EPR2029Y is also available pre-conjugated to a variety of labels for your convenience - HRP, Alexa Fluor® 647, APC (ab197623, ab246715, ab314938).
LEF1 is a transcription factor that promotes tumorigenicity in various cancers by activating pathways like TGF-β. LEF1 also plays a role in maintaining cancer stem cell properties, contributing to chemoresistance and metastasis.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
LEF1 plays a significant role in the regulation of cell fate decisions and development. It acts as part of a transcription complex that binds to specific DNA sequences facilitating the transcription of target genes. LEF1 interacts with β-catenin and this interaction is essential for the regulation of gene expression during embryonic development and cellular proliferation. LEF1's biological functions make it a useful marker in various research applications and assays like LEF1 ELISA are often utilized to study its expression levels in different physiological contexts.
Pathways
LEF1 is a central player in the canonical Wnt/β-catenin signaling pathway. This pathway is fundamental for processes like embryogenesis and cellular growth. LEF1 interacts closely with proteins such as TCF (T-cell factor) family members and β-catenin to regulate gene expression. Disruption in the Wnt pathway where LEF1 is significant can lead to abnormal cell growth and differentiation. Consequently LEF1 serves as an indicator and potential regulator of pathway activities in various cellular environments.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (69)
Recent publications for all applications. Explore the full list and refine your search
Journal of gastrointestinal oncology 14:2178-2191 PubMed37969822
2023
Applications
Unspecified application
Species
Unspecified reactive species
PLoS biology 21:e3002316 PubMed37747910
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 24: PubMed37298583
2023
Applications
Unspecified application
Species
Unspecified reactive species
Exploration (Beijing, China) 3:20220136 PubMed37933235
2023
Applications
Unspecified application
Species
Unspecified reactive species
MedComm 4:e246 PubMed37197086
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of experimental & clinical cancer research : CR 42:105 PubMed37106379
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 14:2417 PubMed37105981
2023
Applications
Unspecified application
Species
Unspecified reactive species
Chemistry & biodiversity 20:e202200768 PubMed36694378
2023
Applications
Unspecified application
Species
Unspecified reactive species
Experimental dermatology 32:491-501 PubMed36579368
2023
Applications
Unspecified application
Species
Unspecified reactive species
Molecular carcinogenesis 62:479-492 PubMed36621979
2023
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
関連製品
Alternative Product
Primary Antibodies
AB85052
Anti-LEF1 antibody
primary-antibodies
lef1-antibody-ab85052
5
(3 reviews)
Alternative Product
Primary Antibodies
AB210627
PE Anti-LEF1 antibody [EP2030Y]
primary-antibodies
pe-lef1-antibody-ep2030y-ab210627
0
(0 reviews)
Alternative Product
Primary Antibodies
AB53293
Anti-LEF1 antibody [EP2030Y]
primary-antibodies
lef1-antibody-ep2030y-ab53293
4
(2 reviews)
Alternative Product
Primary Antibodies
AB227562
Anti-LEF1 antibody [EP2030Y] - BSA and Azide free
primary-antibodies
lef1-antibody-ep2030y-bsa-and-azide-free-ab227562
0
(0 reviews)
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com